Once versus thrice daily gentamicin in patients with serious infections
- 6 February 1993
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 341 (8841), 335-339
- https://doi.org/10.1016/0140-6736(93)90137-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Once-daily aminoglycoside therapyAntimicrobial Agents and Chemotherapy, 1991
- Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in manJournal of Antimicrobial Chemotherapy, 1991
- Determinants of efficacy and toxicity of aminoglycosidesJournal of Antimicrobial Chemotherapy, 1989
- Single, Large, Daily Dosing Versus Intermittent Dosing of Tobramycin for Treating Experimental Pseudomonas PneumoniaThe Journal of Infectious Diseases, 1988
- In Vivo Postantibiotic Effect in a Thigh Infection in Neutropenic MiceThe Journal of Infectious Diseases, 1988
- Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacinAntimicrobial Agents and Chemotherapy, 1987
- Postantibiotic effectsJournal of Antimicrobial Chemotherapy, 1985
- Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982Journal of Antimicrobial Chemotherapy, 1984
- Once-Daily vs. Continuous Aminoglycoside Dosing: Efficacy and Toxicity in Animal and Clinical Studies of Gentamicin, Netilmicin, and TobramycinThe Journal of Infectious Diseases, 1983
- The Influence of Dosage Regimen on Experimental Gentamicin Nephrotoxicity: Dissociation of Peak Serum Levels from Renal FailureThe Journal of Infectious Diseases, 1979